Entrada Therapeutics Inc
Biotechnology
Healthcare
TRDA
41.07 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.28
52 week high
21.59
high
5.36
52 week low
0.00
previous Close
5.28
P/E ratio
market cap
274 M
div yield
0
net profit margin
0.00 %
84.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top